Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
0.669
-0.002 (-0.30%)
At close: Jul 19, 2024, 4:30 PM
0.620
-0.049 (-7.32%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Sensei Biotherapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for SNSE stock have an average target of 4.33, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 547.23% from the current stock price of 0.67.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 3, 2024.
Analyst Ratings
The average analyst rating for SNSE stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 1 | 2 | 2 |
Buy | 0 | 0 | 0 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +497.91% | Jun 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +497.91% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +647.38% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Initiates $5 | Buy | Initiates | $5 | +647.38% | May 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +497.91% | Dec 4, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.15
from -1.22
EPS Next Year
-1.17
from -1.15
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | n/a | n/a |
Avg | n/a | n/a | n/a | n/a | n/a |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.83 | -0.96 | -0.49 | -1.45 | -1.45 |
Avg | -1.15 | -1.17 | -0.97 | -1.41 | -1.41 |
Low | -1.31 | -1.29 | -1.23 | -1.35 | -1.35 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.